1. Home
  2. EPRT vs PTGX Comparison

EPRT vs PTGX Comparison

Compare EPRT & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Essential Properties Realty Trust Inc.

EPRT

Essential Properties Realty Trust Inc.

HOLD

Current Price

$30.14

Market Cap

6.6B

Sector

Real Estate

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$97.00

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPRT
PTGX
Founded
2016
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
6.4B
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
EPRT
PTGX
Price
$30.14
$97.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
13
Target Price
$36.79
$108.23
AVG Volume (30 Days)
1.3M
480.8K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
3.98%
N/A
EPS Growth
11.30
N/A
EPS
0.28
0.05
Revenue
$561,219,000.00
N/A
Revenue This Year
$17.12
$874.25
Revenue Next Year
$16.27
N/A
P/E Ratio
$108.11
$1,947.60
Revenue Growth
24.82
N/A
52 Week Low
$28.95
$49.86
52 Week High
$34.73
$107.84

Technical Indicators

Market Signals
Indicator
EPRT
PTGX
Relative Strength Index (RSI) 39.73 46.14
Support Level $29.24 $96.36
Resistance Level $30.39 $104.85
Average True Range (ATR) 0.52 4.36
MACD -0.08 -0.29
Stochastic Oscillator 28.04 36.84

Price Performance

Historical Comparison
EPRT
PTGX

About EPRT Essential Properties Realty Trust Inc.

Essential Properties Realty Trust Inc is a real estate investment trust. It is an internally managed real estate company acquires, owns and manages single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses. The Company generally invests in and leases freestanding, single-tenant commercial real estate facilities where a tenant services its customers and conducts activities that are essential to the generation of the tenant's sales and profits.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: